EdgarLookup

Telix Pharmaceuticals Ltd — All Filings

75 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 20-F 20-F/A 20FR12B 20FR12B/A 3 6-K 8-A12B CERT CORRESP DRS DRS/A EFFECT F-1 F-1/A F-3ASR F-6 RW S-8 SCHEDULE 13G SEC STAFF ACTION SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SEC STAFF LETTER 9999999997-24-004398 Nov 21, 2024
6-K 6-K 0001140361-24-047244 Nov 19, 2024
6-K 6-K 0001140361-24-046707 Nov 14, 2024 Nov 12, 2024
CERT 0001354457-24-000860 Nov 12, 2024
EFFECT 9999999995-24-003460 Nov 12, 2024
SEC STAFF ACTION 9999999997-24-004310 Nov 12, 2024
CORRESP 0001140361-24-046048 Nov 12, 2024
20FR12B/A 20FR12B/A 0001140361-24-044557 Oct 30, 2024
SEC STAFF LETTER 9999999997-24-004217 Oct 28, 2024
CORRESP 0001140361-24-043620 Oct 17, 2024
F-6 0001193805-24-001251 Oct 17, 2024
20FR12B 20FR12B 0001140361-24-043618 Oct 17, 2024
UPLOAD 0000000000-24-011485 Oct 10, 2024
DRS 0001140361-24-040995 Sep 13, 2024
RW RW 0001140361-24-030136 Jun 14, 2024
RW RW 0001140361-24-030120 Jun 14, 2024
8-A12B 8-A12B 0001140361-24-029566 Jun 10, 2024
F-1/A F-1/A 0001140361-24-028932 Jun 5, 2024
F-6 0001193805-24-000723 May 30, 2024
F-1 F-1 0001140361-24-026584 May 17, 2024
DRS/A 0001140361-24-025016 May 9, 2024
DRS/A 0001140361-24-019882 Apr 15, 2024
DRS/A 0001140361-24-013335 Mar 15, 2024
DRS/A 0001140361-24-005348 Feb 2, 2024
DRS 0001140361-24-003917 Jan 25, 2024